BCRX (BIOCRYST PHARMACEUTICALS INC) Institutional Ownership Summary
Based on the latest SEC 13F filings, 6 institutional investors hold BCRX (BIOCRYST PHARMACEUTICALS INC) with a combined value of $226.60M across 29,050,689 shares. The largest holder is BlackRock, Inc. with a position worth $164.87M (0.00% of their portfolio). 3 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$226.60M
Total Shares Held
29,050,689
Institutional Holders
6
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $164.87M | 0.00% | -0.5% |
| 2 | BAKER BROS. ADVISORS LP | $22.02M | 0.13% | +0.0% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $16.60M | 0.03% | -0.5% |
| 4 | CITADEL ADVISORS LLC | $11.80M | 0.00% | +0.5% |
| 5 | Point72 Asset Management, L.P. | $9.47M | 0.01% | +409.5% |
| 6 | Bridgewater Associates, LP | $1.84M | 0.01% | -42.8% |